Oxford Biotherapeutics (OBT) is a clinical‑stage biotechnology company developing innovative antibody‑based therapeutics for the treatment of cancer. You will contribute directly to the pre‑clinical development of our immuno‑oncology pipeline. Our proprietary OGAP® platform, the world’s largest cancer‑specific membrane protein library enables the discovery of novel, highly tumour‑specific antigens for first‑in‑class ADC, Bispecific T‑cell Engager (BITE®), and CAR‑based therapeutics. Our lead asset, OBT076, is in Phase 1b clinical development, supported by a strong internal and partnered pipeline with leaders such as Roche, Boehringer Ingelheim, and Zymeworks. As an Antibody Discovery Associate Scientist/Scientist, you will play a key role in discovering both tool and therapeutic antibodies using state‑of-the-art in vivo and in vitro approaches. You’ll collaborate closely with cross‑functional teams, contribute to experimental design, and help drive projects forward in a fast‑paced, highly innovative environment. This role is an excellent fit for someone who is proactive, detail‑oriented, scientifically curious, and excited to work on cutting‑edge antibody discovery pipelines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees